David A. Sclar

ORCID: 0000-0002-0983-4293
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Health Systems, Economic Evaluations, Quality of Life
  • Pharmaceutical Economics and Policy
  • Pharmaceutical Practices and Patient Outcomes
  • Schizophrenia research and treatment
  • Treatment of Major Depression
  • Medication Adherence and Compliance
  • Attention Deficit Hyperactivity Disorder
  • Mental Health Treatment and Access
  • Pharmaceutical studies and practices
  • Opioid Use Disorder Treatment
  • Child and Adolescent Psychosocial and Emotional Development
  • Medieval and Classical Philosophy
  • Historical and Linguistic Studies
  • Pharmaceutical industry and healthcare
  • Healthcare Policy and Management
  • Maternal Mental Health During Pregnancy and Postpartum
  • Electroconvulsive Therapy Studies
  • Anesthesia and Sedative Agents
  • Antibiotics Pharmacokinetics and Efficacy
  • Blood Pressure and Hypertension Studies
  • Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Diabetes Management and Research
  • Diabetes Management and Education
  • Sephardic Jews and Inquisition Studies
  • Drug-Induced Adverse Reactions

Princeton University
2016-2024

Harvard University Press
2006-2021

Midwestern University
2013-2019

IS practice
2017

University of Toronto
2015

Washington State University Spokane
2000-2013

Washington State University
2001-2012

University of North Texas
2012

University of North Texas Health Science Center
2012

Boehringer Ingelheim (United States)
2012

10.1016/j.amjmed.2013.09.007 article EN The American Journal of Medicine 2013-09-30

The abuse potential of gabapentin is well documented; with having been noted as an agent highly sought after for use in potentiating opioids. When combined opioids, the risk respiratory depression and opioid-related mortality increases significantly. In US, was approved by Food Drug Administration a non-controlled substance. To date, spite empirical evidence suggestive diversion remains substance at federal level. This has forced individual US states jurisdictions - often significantly...

10.2147/rmhp.s168504 article EN cc-by-nc Risk Management and Healthcare Policy 2018-08-01

Objective: The aim of this article is to update ADHD diagnosis/treatment trends by age, gender, and race. Method: National Ambulatory Medical Care Survey data were obtained for 2008-2009 2012-2013. Physician office visits including diagnosis pharmacotherapy measured per 1,000 population overall, demographic group. Logistic regression models controlled demographics, psychiatric comorbidities, insurance type, time period. Interactions time, type tested. Results: Diagnoses increased 36% in...

10.1177/1087054716688534 article EN Journal of Attention Disorders 2017-02-02

Abstract Introduction Proton pump inhibitors (PPI) have been linked to Clostridium difficile infection (CDI) but there are few data specific ICU patients. We evaluated duration of PPI exposure as a potential risk factor for hospital-acquired CDI in the ICU. Methods This retrospective, case-control study was conducted using Multiparameter Intelligent Monitoring Intensive Care II database, large publically available database more than 35,000 Adult patients with were identified ICD-9 code...

10.1186/s13054-014-0714-7 article EN cc-by Critical Care 2014-12-19

The present study was designed to compare direct health service expenditures, for the treatment of depression, among patients enrolled in a maintenance organization, and prescribed one three selective serotonin reuptake inhibitors, fluoxetine, paroxetine or sertraline. Information regarding depression-related use derived from computer archive network-model organization system serving 700 000 beneficiaries. A total 744 beneficiaries were found satisfy selection criteria. Multivariate...

10.1177/030006059502300601 article EN Journal of International Medical Research 1995-11-01

An estimated 20 million Americans suffer from diabetes. Patients with non–insulin–dependent diabetes mellitus (NIDDM) comprise approximately 90% of the diabetic population. 10–30% patients NIDDM withdraw their prescribed regimen within 1 year diagnosis, and remainder, nearly 20% administer insufficient medication to facilitate an adequate reduction in blood glucose. A randomized trial was undertaken discern effect pharmacy–based value–added utilities on prescription–refill compliance...

10.1111/j.1365-2710.1993.tb00591.x article EN Journal of Clinical Pharmacy and Therapeutics 1993-08-01

The effectiveness of a collaborative pharmacist-nurse intervention on resolving detected medication discrepancies as patients transitioned from hospital to home health care was evaluated.Patients age 50 years or older who were transitioning with qualifying diagnoses eligible for study inclusion. Patients assigned control group based the geographic location patients' home. For group, coordinator initiated consultation nurse case manager facilitate discrepancy resolution. in received usual...

10.2146/ajhp080582 article EN American Journal of Health-System Pharmacy 2009-11-04

Research suggests the medical consequences of gabapentin overuse depend on whether is abused alone or with opioids to potentiate an opioid "high." The objective this study was assess predictors without concomitant opioids.Data were obtained from Truven Health MarketScan® Commercial Claims and Encounters database for 2013 through 2015. Eligibility criteria utilization, opioids, 120 days longer throughout a 12-month observation period. Cohort identification based patterns exceeding thresholds...

10.1002/phar.2096 article EN Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy 2018-02-27

The objective of this study is to discern ethnic/race-specific (black, Hispanic, white) population-adjusted rates US office-based visits documenting a diagnosis depression, and the extent use antidepressant pharmacotherapy for its treatment. Data from National Ambulatory Medical Care Survey time-frames 1992–1997, 2003–2004, were partitioned into four, 2-year time intervals trend analysis among patients aged 20–79 years. From 1992–1993 annualized rate depression increased 10.9 15.4 per 100...

10.1097/yic.0b013e3282f2b3dd article EN International Clinical Psychopharmacology 2008-03-01

This study was designed to identify determinants of breast and cervical cancer screening among rural, low-income Hispanic women using migrant health clinics in eastern Washington state. Five hundred twelve foreign-born were interviewed. Odds ratios 95 percent confidence intervals generated via logistic regression analysis used discern the influence independent factors on use or nonuse Papanicolaou (Pap) smear, self-examination (BSE), mammography. Being married, having a higher income, more...

10.1353/hpu.2010.0465 article EN Journal of Health Care for the Poor and Underserved 1996-01-01

Objective: To examine the association between pharmacy prescription refill adherence by type of oral antihyperglycaemic medications used in seniors Nova Scotia, Canada. Research design and methods: Pharmacy health care utilization data from April 1993 to March 1996 for Scotia Seniors' Pharmacare beneficiaries treated with 1st 2nd generation sulphonylureas biguanides was analysed. Refill quantified two proportions: number days had a medication surplus compared total period observation gaps...

10.1046/j.1365-2710.2002.00411.x article EN Journal of Clinical Pharmacy and Therapeutics 2002-06-01

Little is known about the prescribing pattern for antidepressant pharmacotherapy by ethnicity. The present study was designed to determine rates of office-based visits documenting utilization pharmacotherapy, a diagnosis depressive disorder, or both, among whites, blacks, and Hispanics age 20-79 years. Data from National Ambulatory Medical Care Survey 1992-93 1994-95 were utilized this analysis. Comparing these time periods, we observed several trends: (1) annualized mean rate per 100 US...

10.1093/hrp/7.1.29 article EN Harvard Review of Psychiatry 1999-05-01
Coming Soon ...